Braintree Hits Amrutham With Laxative Patent Suit
Braintree Laboratories Inc. filed an infringement action in Pennsylvania on Wednesday to block Amrutham Inc. from marketing a generic version of the laxative drug Suprep, days after pouncing on Novel Laboratories...To view the full article, register now.
Already a subscriber? Click here to view full article